Key result
Manifesting carriers of Duchenne muscular dystrophy exhibited skewed X inactivation, whereas unaffected carriers showed almost symmetrical inactivation.
Why the study?
Does the pattern of X inactivation differ between manifesting carriers, unaffected carriers of Duchenne muscular dystrophy, and healthy controls?
Observational (n=41)
Does the pattern of X inactivation differ between manifesting carriers, unaffected carriers of Duchenne muscular dystrophy, and healthy controls?
Skewed X inactivation is strongly associated with manifesting Duchenne muscular dystrophy in female carriers and may provide important prognostic information for progressive myopathy.
Answers are grounded in this paper and cite their sources.
Skewed X inactivation was associated with manifesting DMD carriers; hypothesis-generating for prognosis, needs prospective validation before clinical use.
We studied X inactivation patterns in manifesting carriers of familial and sporadic Duchenne muscular dystrophy (DMD) or unaffected carriers of DMD by analysis of the methylation of HpaII sites in the first exon of the human androgen-receptor gene (HUMARA) from peripheral blood samples. Three of the four manifesting carriers, four of the five asymptomatic carriers, and 31 of the 32 female controls were heterozygous for the CAG repeat of HUMARA. All manifesting carriers showed skewed X inactivation, while all unaffected carriers showed almost symmetrical inactivation. One family studied over three generations is noteworthy because it includes two mother/daughter pairs, one an affected pair with skewed X inactivation, and the other a phenotypically normal carrier pair with random X inactivation. On the other hand, the extent of X inactivation for each X chromosome in 31 female controls was widely distributed. These data suggest that in carriers of DMD, both affected and unaffected, it is valuable to analyze the pattern of skewed X inactivation because it provides important prognostic information. Carriers of DMD with skewed X inactivation might show slowly progressive myopathy with advancing age.
No takes yet. Share an insight, caveat, or question.
Yoshioka et al. (1998) conducted an observational in Duchenne muscular dystrophy (n=41). Manifesting DMD carrier status vs. Unaffected DMD carriers and healthy female controls was evaluated on X inactivation pattern (skewed vs symmetrical). Manifesting carriers of Duchenne muscular dystrophy exhibited skewed X inactivation, whereas unaffected carriers showed almost symmetrical inactivation.
Synapse has enriched 10 related papers. Consider them for comparative context: